Combined analysis of IGHV mutations, telomere length and CD49d identifies long-term progression-free survivors in TP53 wild-type CLL treated with FCR-based therapies

Pepper, Andrea G.S.; Zucchetto, Antonella; Norris, Kevin; Tissino, Erika; Polesel, Jerry; Soe, Zarni; Allsup, David; Hockaday, Anna; Ow, Pei Loo; Hillmen, Peter; Rawstron, Andrew; Catovsky, Daniel; Bulian, Pietro; Bomben, Riccardo; Baird, Duncan M.; Fegan, Christopher D.; Gattei, Valter; Pepper, Chris

doi:10.1038/s41375-021-01322-1

Combined analysis of IGHV mutations, telomere length and CD49d identifies long-term progression-free survivors in TP53 wild-type CLL treated with FCR-based therapies

Pepper, Andrea G.S.; Zucchetto, Antonella; Norris, Kevin; Tissino, Erika; Polesel, Jerry; Soe, Zarni; Allsup, David; Hockaday, Anna; Ow, Pei Loo; Hillmen, Peter; Rawstron, Andrew; Catovsky, Daniel; Bulian, Pietro; Bomben, Riccardo; Baird, Duncan M.; Fegan, Christopher D.; Gattei, Valter; Pepper, Chris

Authors

Andrea G.S. Pepper

Antonella Zucchetto

Kevin Norris

Erika Tissino

Jerry Polesel

Zarni Soe

Professor David Allsup D.J.Allsup@hull.ac.uk
Professor of Haematology

Anna Hockaday

Pei Loo Ow

Peter Hillmen

Andrew Rawstron

Daniel Catovsky

Pietro Bulian

Riccardo Bomben

Duncan M. Baird

Christopher D. Fegan

Valter Gattei

Chris Pepper

Citation

Pepper, A. G., Zucchetto, A., Norris, K., Tissino, E., Polesel, J., Soe, Z., Allsup, D., Hockaday, A., Ow, P. L., Hillmen, P., Rawstron, A., Catovsky, D., Bulian, P., Bomben, R., Baird, D. M., Fegan, C. D., Gattei, V., & Pepper, C. (2021). Combined analysis of IGHV mutations, telomere length and CD49d identifies long-term progression-free survivors in TP53 wild-type CLL treated with FCR-based therapies. Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K, https://doi.org/10.1038/s41375-021-01322-1

Journal Article Type	Article
Acceptance Date	Jun 3, 2021
Online Publication Date	Jun 19, 2021
Publication Date	Jun 19, 2021
Deposit Date	Jun 21, 2021
Publicly Available Date	Jun 22, 2021
Journal	Leukemia
Print ISSN	0887-6924
Publisher	Nature Publishing Group
Peer Reviewed	Peer Reviewed
DOI	https://doi.org/10.1038/s41375-021-01322-1
Keywords	Chronic lymphocytic leukaemia; Translational research
Public URL	https://hull-repository.worktribe.com/output/3792182

This output contributes to the following UN Sustainable Development Goals:

Ensure healthy lives and promote well-being for all at all ages

Files

Published article (734 Kb)
PDF

Copyright Statement
© The Author(s) 2021. Open Access. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.